Entry

D10851            Mixture   Drug

Name

Efavirenz, emtricitabine and tenofovir disoproxil;
Atripla (TN)

Product

ATRIPLA (Gilead Sciences)

Generic

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Exelan Pharmaceuticals), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (REMEDYREPACK), EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA)

Component

Efavirenz [DR:D00896], Emtricitabine [DR:D01199], Tenofovir disoproxil fumarate [DR:D01982]

Class

Antiviral
DG03107 Anti-HIV agent

Remark

ATC code:

J05AR06

Product:

D10851<US>

Efficacy

Antiviral

Disease

HIV-1 infection [DS:H01563]

Target

HIV-1 reverse transcriptase [KO:K24802]

Pathway

ko03230

Viral genome structure

ko03240

Viral replication

ko03250

Viral life cycle - HIV-1

Interaction

Brite

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
      D10851  Efavirenz, emtricitabine and tenofovir disoproxil <US>
USP drug classification [BR:br08302]
Antivirals
  Anti-HIV Combinations
   Efavirenz/ Emtricitabine/ Tenofovir Disoproxil Fumarate
    D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Drug groups [BR:br08330]
Antiviral
  DG03107  Anti-HIV agent
   D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Drug classes [BR:br08332]
Antiviral
  DG03107  Anti-HIV agent
   D10851  Efavirenz, emtricitabine and tenofovir disoproxil
Antimicrobials [BR:br08307]
Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D10851  Efavirenz, emtricitabine and tenofovir disoproxil <US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
  D10851

Other DBs

CAS:	731772-50-2

PubChem:

319902651